Telemos Capital

Canaccord Genuity has Advised Telemos Capital on its Investment in Helios Global Group

Canaccord Genuity is pleased to announce it has advised Telemos Capital (“Telemos”), a European mid-market private equity firm backed by family capital, on its investment partnership with Helios Global Group (“Helios”), a leading full-service healthcare communications provider. 

Helios provides high-quality and impactful healthcare communications, as well as health economic and market access solutions following its acquisition of Cogentia in February this year. Helios’ existing leadership team will continue to manage the business, expanding the client base and global operations while maintaining its core focus on sustainable organic growth. 

Telemos’ investment will support the group in its future ambitions expanding into new service lines, harnessing innovative technologies and continuing to scale its internal infrastructure to support its client base.

Completion is expected in October 2024 and is subject to customary approvals.

Sami Kassam, Managing Director at Telemos, shared his experience working with Canaccord Genuity saying, “CG have a long track record in pharma services and bring an international perspective to their work, so we were glad to have the support of their high quality team as we made this investment.”